Understand the source comparison
DSIP Cortisol Modulation: Method Comparison
Different DSIP administration routes and adjunct interventions produce distinct cortisol modulation profiles. The table below compares subcutaneous injection, intranasal delivery, and combination protocols with sleep hygiene or adaptogen co-administration. Sub
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different DSIP administration routes and adjunct interventions produce distinct cortisol modulation profiles. The table below compares subcutaneous injection, intranasal delivery, and combination protocols with sleep hygiene or adaptogen co-administration.
- Subcutaneous DSIP (0.5–1.5 nmol/kg)
- 20–31% reduction in stress-induced cortisol elevation
- 60–90 minutes
- 4–6 hours from administration
- Most consistent HPA modulation; requires aseptic reconstitution and refrigerated storage; preferred for research models
- Intranasal DSIP (25–30 µg)
- 15–28% reduction; faster CNS penetration but variable mucosal absorption
- 20–40 minutes
- 3–5 hours; shorter-acting than subcutaneous
- Higher bioavailability variance (40–70%); convenient for human trials but less predictable than injection
- DSIP + Sleep Hygiene (light control, fixed sleep schedule)
- 28–35% reduction; additive effect on evening cortisol
- 6–8 hours; extends into early sleep cycles
- Synergistic modulation; sleep hygiene stabilizes circadian cortisol rhythm while DSIP tightens HPA feedback
- DSIP + Phosphatidylserine (400 mg)
- 25–40% reduction; phosphatidylserine attenuates post-exercise cortisol
- 45–75 minutes
- 5–7 hours
- Combined mechanism: DSIP modulates CRH, phosphatidylserine blunts ACTH response; well-studied in athletic populations
- Placebo / No Intervention
- 0–5% variation; cortisol follows diurnal curve without modulation
- N/A
- Baseline comparison; illustrates magnitude of DSIP's regulatory impact
- Subcutaneous administration remains the gold standard for reproducible DSIP cortisol modulation in controlled research settings. Intranasal delivery offers practical advantages for human compliance but introduces absorption variability that can reduce statistical power in small-sample trials. Combination protocols with sleep hygiene or cortisol-attenuating compounds like phosphatidylserine demonstrate additive effects, suggesting DSIP's HPA modulation complements rather than replaces behavioral and nutritional interventions.